Healthtech Log my Care closes £2m venture debt from Palatine Growth Credit
This article covers Log my Care, a healthtech startup, closing a £2m venture debt facility with Palatine Growth Credit to fund product development and an artificial intelligence roadmap for its digital care management platform. The funding is intended to support development of AI-driven care-plan and risk-prediction features to help care providers and frontline staff across the UK deliver more preventative and safer care.
Log my Care has closed a £2 million Venture Debt facility with Palatine Growth Credit to fund product development and an artificial intelligence roadmap aimed at strengthening its digital care management platform. The deal is notable because it uses venture debt rather than equity, allowing the business to pursue growth and technology investment while preserving founder ownership during a period of leadership transition.
Why it matters
The funding arrives at a time when digital tools for social and community care face pressure to deliver better outcomes with limited resources. Log my Care says its software is used by more than 1,000 customers across the United Kingdom, who support about 30,000 service users, and the company holds NHS Assured Supplier status. For providers managing complex care needs, incremental improvements to care planning and risk prediction can translate into measurable gains in safety and preventative support.
The choice of venture debt highlights an alternative route for healthtech companies that need capital for technology builds but wish to avoid further equity dilution. For a sector that often relies on long procurement cycles and regulatory scrutiny, access to non-dilutive capital can speed product work without changing ownership structures.
Inside the product
Founded in 2017, Log my Care offers B2B SaaS for care management with a focus on complex care planning. The platform centralises care plans and operational records, aiming to make it easier for care workers to follow consistent procedures and for providers to evidence quality.
The company says the new facility will be directed at feature enhancements, particularly the development of AI-driven care-plan tools and risk prediction models. These capabilities are pitched to help frontline staff prioritize preventative interventions and to surface risks earlier, which in turn could reduce incidents and reliance on reactive services.
InvestorSection
Who are the investors?
Palatine Growth Credit is the lender providing the £2 million Venture Debt facility. The firm positions growth credit as a way to support established businesses through capital for scaling or product investment without immediate equity issuance. In this case Palatine framed the decision around Log my Care’s growth to date, its focus on practical tools for care workers and its suitability for the regulated NHS-linked market.
In the announcement, Ryan Sorby, Partner and Head of the North at Palatine, said:
Log my Care is exactly the kind of business that Palatine likes to work with. The team have been on a fantastic growth journey so far, while also staying true to their principles to enable care workers to do their job more effectively and to ensure high quality benefit those most vulnerable in society.
Founder perspective
The funding coincides with a leadership change. Founder and former CEO Sam Hussain has moved into a Founder Director role, and Matt Russell has joined as CEO. Russell brings more than 20 years of experience in HR and workplace technology, most recently leading benefits platform Zest through growth and its acquisition by Epassi Group.
In the announcement, Sam Hussain, Founder Director at Log my Care, said:
This funding enables another step in our vision to make preventative care a reality. We are excited to be partnering with the Palatine team to enhance quality of care for many thousands of people.
In the announcement, Matt Russell, Chief Executive Officer at Log my Care, said:
We are delighted to be partnering with Palatine, and this funding will be used for further enhancements in the platform including building on our AI capabilities.
The bigger picture
Venture debt is becoming a more visible option for UK healthtech companies that have product-market fit and predictable revenue but prefer to limit equity dilution before a larger growth or exit event. For firms operating in the care market, the interaction with NHS procurement and regulatory standards often favours proven, revenue-generating businesses when lenders assess risk.
Log my Care’s use of credit to back AI and preventative-care features reflects a broader trend: investors and lenders are allocating capital to software that can demonstrate operational impact in health and social care. If the platform’s enhancements lead to measurable reductions in risk or workload, the company could strengthen its position in a crowded healthtech landscape and provide a case study for non-dilutive financing in the sector.
The deal underlines how UK healthtech companies are funding product advances within the constraints of public-sector procurement and growing interest from specialist lenders and healthtech investors in scalable, operationally focused businesses.
They've invested in Log my Care
Get to know these healthtech investors
| Investors | Investment Focus | Startup Investments | Round Size | Connect |
|---|---|---|---|---|
 Palatine Growth Credit( ) | ||||
| All investors | All investor sectors | All funded startups | All funding rounds |
Click here for a full list of 7,589+ startup investors in the UK